Eric Swayze, EVP Research at IONIS PHARMACEUTICALS INC (IONS), sold 53 shares at $73.62 ($4K) on 2025-10-16, disclosed to the SEC on 2025-10-16.
Open-market sale of $4k IONS by EVP Research. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| Filing → |
| IONS | SELL | 2026-02-02 | $512K | — | Filing → |
| IONS | SELL | 2026-01-20 | $748K | — | Filing → |
| IONS | SELL | 2026-01-06 | $1.9M | — | Filing → |